Company Overview

Development Stage

About the Company

公司介绍:天津阿斯尔生物科技有限公司的母公司英国RSR有限公司,是一家有40年历史的医疗诊断试剂的开发商和生产商,产品在自身免疫性甲状腺疾病、1型糖尿病、神经免疫和其他自身免疫性疾病诊断中有广泛应用。RSR还为其他医疗诊断试剂制造商提供高质量的试剂。公司产品远销欧盟、美国、日本、中国等海外市场。公司的创始人Dr Bernard Ree Smith联合其他学者首次证实了Graves病患者血清中的长效甲状腺刺激因子(LATS)实质上是特异性靶向TSHR的自身抗体(即TRAb),而TRAb对TSHR的刺激是造成Graves病患者甲状腺功能亢进的病因。这一研究结果促进了*代TRAb体外检测方法的发展,为自身免疫性甲状腺疾病(AITD)的辅助诊断和管理提供依据,并在后来对该抗体的检测研究做出多项里程碑的贡献,因此RSR被授予了三次英国女王奖。长久以来,RSR公司一直致力于抗原抗体在分子水平上相互作用的前沿研究,上百项研究成果在科学会议及重要的学术期刊上发表。The CompanyRSR is a well-established developer producer of medical diagnostics with key applications in autoimmune thyroid disease, type 1 diabetes mellitus, neuroimmunology other autoimmune diseases. RSR also provides high quality reagents fmedical diagnostic manufacturers. The company’s products are exported to overseas markets including the European Union, the USA, Japan China. The company has a long history of cutting edge research in particular on the interaction between autoantigens autoantibodies at the molecular level. These are presented at scientific meetings published in scientific journals.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Recruitment Overview / Current Status (11 open positions)

Manage
Note: How fast is hiring at 天津阿斯尔生物科技有限公司 growing? 2025: 3 openings, 2023: 1 openings, 2022: 11 openings, 2021: 16 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

— What Are the Salaries Like? (13 records)

Manage
salary range: 3K - 10K, 100% of roles pay ¥3-10K
Note: salary statistics are based on 13 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 天津阿斯尔生物科技有限公司?100% of positions earn 3-10K, Undergraduate salary: ¥。工厂生产类 average salary ¥6.4K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Job Category

  • 工厂生产类
    53.8% of total 53.8%
  • 医疗卫生/美容保健类
    38.5% of total 38.5%
  • 在校学生类
    30.8% of total 30.8%
  • 销售类
    23.1% of total 23.1%

Education

  • 本科
    61.5% of total 61.5%
  • 硕士
    23.1% of total 23.1%
  • 不限
    15.4% of total 15.4%

Experience

  • 不限
    100% of total 100%
View Detailed Analysis

What does 天津阿斯尔生物科技有限公司 require? Who is 天津阿斯尔生物科技有限公司 hiring? recruitment: 工厂生产类占比最多占53.8%,其次是医疗卫生/美容保健类占38.5%. What education can get in at ? 本科占比最多占61.5%,其次是硕士占23.1%. High education required at ? 硕士占23.1%. Work experience required at ? 不限占比最多占100%. Where are the job locations at ? 天津占比最多占100%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 300万(元)
Legal Representative: BERNARD REES SMITH
Date Established:
Credit Code: 91120116066853014X
Registered Address: 天津滨海高新区华苑产业区海泰发展六道6号海泰绿色产业基地J座312室

People who follow this company also follow

Competitors (Similar Companies)

“A leader in the diabetes field”
“慢病管理的有力践行者”
“发展生命科学技术,提升人类健康”
“Technological innovation and commercial application of pharmaceutical ”
“R&D, production and commercialization of high-quality human vaccines”
医疗器械 POCT 试剂 体外诊断试剂
“Comprehensive Solutions for Medical Diagnosis”
医院 健康管理 慢性病服务 骨科
人力资源 知识产权 专利代理 知识产权代理
医疗科技 经销商 医学科技 产品分销

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates